Expert pharmaceutical industry training from Thomson Reuters
This modular online course will bring you rapidly up to speed on global regulatory affairs, delivering an unparalleled depth of information and procedural knowledge to your desktop.
Regulatory Online Learning provides access to relevant IDRAC® documents, recognized by regulatory professionals the world over as the leading authority in respected industry information.
- Comprehensive — the 23 modules guide you through all relevant territories worldwide
- Accurate — designed and developed by our team of IDRAC experts, assisted by an international network of consultants and partners
- Up-to-date — continuously updated to reflect the very latest developments
- Driven by you — follow the entire course as a complete guide to regulatory affairs, or drop in to the module that interests you
Regulatory Online Learning can help you to:
- gain a solid grounding in global regulatory affairs
- learn how the pharmaceutical industry operates
- refresh your knowledge or stay on top of the ever-shifting regulatory landscape
- develop and implement a regulatory strategy for your chosen markets
- optimize your success in dealing with regulatory authorities
- identify potential risks to approval and devise strategies to deal with them
- accelerate your product’s entrance into the worldwide marketplace
|
Course level |
Course name |
|
Introductory |
Introduction to the European Union Institutions and Regulatory Authority (EMEA) |
|
Introductory |
Introduction to US Institutions and Regulatory Authority (FDA) |
|
Introductory |
Introduction to Japanese Institutions and Regulatory Authorities |
|
Introductory |
Overview of the CTD and the e-CTD |
|
Introductory |
Introduction to the International Conference on Harmonization (ICH) |
|
Introductory |
The Regulatory Development Cycle of a Drug |
|
Introductory |
Basics of Pharmacovigilance |
|
Introductory |
Basics of Clinical Trials* |
| Introductory |
日本の薬事行政機関と規制 (Introduction to Japanese Regulatory Institutions and Pharmaceutical Review) |
|
Practical |
How to Register Medicinal Products through the Centralized Procedure |
|
Practical |
How to Register Medicinal Products through the Decentralized Procedure |
|
Practical |
How to Register Medicinal Products through the Mutual Recognition Procedure |
|
Practical |
How to Prepare for an FDA Advisory Committee Meeting |
|
Practical |
How to Register a New Drug in the USA |
|
Practical |
How to Maintain Marketing Approvals in Europe for Centrally Authorized Products |
|
Practical |
How to deal with a Pharmacovigilance Inspection* |
|
Strategic |
Regulatory Provisions for Expediting the access to Innovative Medicines in the United States and in Europe |
|
Strategic |
Access to Unapproved Drugs through Compassionate use |
|
Strategic |
Regulatory Requirements for the Conduct of Clinical Trials in Europe |
| Strategic |
Orphan Drugs in Europe, USA and Japan |
|
Strategic |
Regulatory Requirements for the Conduct of Clinical Trials in the USA (INDs) |
|
Strategic |
Meeting Opportunities with Agencies |
|
Strategic |
Risk Management* |
* These courses are currently under development
Click to access an audio and powerpoint presentation of Regulatory Online Learning
|